TFEB can also be activated by other treatments for hepatic steatosis, including ezetimibe [105], procyanidin B2 [106], formononetin [107], liraglutide [108], fenofibrate [109], and metformin [110]. The gene discussed is TFEB; the disease is Hepatic steatosis.